Brickell Biotech

Brickell Biotech Gross Margin

Delisted

The Gross Margin of Brickell Biotech (BBI) as of Oct 18, 2026 is 100.00 %. In the previous year, Gross Margin was 100.00 % — a change of 0.00% (lower).

Gross Margin

100.00 %

YoY

0.00%

Last updated:

Gross Margin of Brickell Biotech is 2021 100.00 % . Gross Margin of Brickell Biotech was 2020 100.00 % . It decreases by 0.00% lower compared to the previous year.

Brickell Biotech's gross margin stands at 100.0%, up from 53.1% several years earlier.

The Brickell Biotech Gross Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Gross Margin
Date
Gross Margin
Jan 1, 2014
28.87 USD
Jan 1, 2015
47.84 USD
Jan 1, 2016
56.71 USD
Jan 1, 2017
53.12 USD
Jan 1, 2018
11.47 USD
Jan 1, 2019
100.00 USD
Jan 1, 2020
100.00 USD
Jan 1, 2021
100.00 USD
The Brickell Biotech Gross Margin history
YEARGross MarginYoY
100.00 %0.00%
100.00 %0.00%
100.00 %+772.04%
11.47 %-78.41%
53.12 %-6.33%
56.71 %+18.53%
47.84 %+65.72%
28.87 %-4,574.12%
-0.65 %-164.52%
1.00 %+51.98%
0.66 %-310.33%
-0.31 %-131.28%
1.00 %0.00%
1.00 %0.00%
1.00 %0.00%
1.00 %0.00%
1.00 %0.00%
1.00 %0.00%
1.00 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Brickell Biotech Stock analysis

What does Brickell Biotech do? Brickell Biotech Inc is a biopharmaceutical company that focuses on the development and marketing of innovative dermatology products. The company was founded in 2009 and is headquartered in Boulder, Colorado (USA), with branches in California and Singapore. The history of Brickell Biotech dates back to the 1960s when the company was originally founded under the name Brickell Research Inc. Over the following decades, the company specialized in biological research and conducted important research that forms the basis for today's product development. Brickell Biotech's business model is based on the creation of new and innovative therapies for the treatment of various dermatological diseases. In recent years, the company has entered into a number of important partnerships to accelerate its product development and strengthen its position in the industry. Brickell Biotech operates in two main areas: pharmaceuticals and cosmetic products. In the pharmaceuticals area, the company has a number of promising therapies in the pipeline that target the treatment of skin cancer, psoriasis, and other dermatological conditions. The company's flagship product is Sofpironium Bromide, a potential treatment for hyperhidrosis (excessive sweating). In the cosmetic products area, the company has developed a range of skincare products tailored to the needs of people with sensitive, dry, or aging skin. These products include moisturizers, cleansers, and anti-aging products, all made from high-quality ingredients. Brickell Biotech works closely with the scientific community to explore the latest developments and innovations in dermatology and the cosmetics industry. The company has also established a strong presence in the medical and research sectors by collaborating closely with leading universities and medical institutions worldwide. Overall, Brickell Biotech is a promising company in the biopharmaceutical and cosmetics industry, specializing in the development of new and innovative therapies for the treatment of skin conditions. With a strong pipeline of products and a dedicated leadership team, the company is expected to continue growing and establish itself as an important player in the industry. Brickell Biotech is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Brickell Biotech stock

Gross Margin of Brickell Biotech is 100.00 % in 2021.

Gross Margin of Brickell Biotech changed from 100.00 % to 100.00 %, representing a 0.00% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Gross Margin Brickell Biotech since 2006 – with annual values, charts, and detailed analysis.

Gross Margin measures the percentage of revenue remaining after COGS. Higher gross margins indicate more efficient production and stronger pricing power.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Gross Margin's Brickell Biotech with sector peers and the industry average to assess whether it is attractive.

To evaluate Gross Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Gross Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — Brickell Biotech

All Key Metrics — Brickell Biotech